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Nisin is an antimicrobial peptide produced and secreted by several L. lactis strains and is speciﬁcally active against Gram-positive
bacteria. In previous studies, nisin was puriﬁed via cation exchange chromatography at low pH employing a single-step elution
using 1M NaCl. Here, we describe an optimized puriﬁcation protocol using a ﬁve-step NaCl elution to remove contaminants.
The obtained nisin is devoid of impurities and shows high bactericidal activity against the nisin-sensitive L. lactis strain NZ9000.
Puriﬁed nisin exhibits an IC50 of ∼3nM, which is a tenfold improvement as compared to nisin obtained via the one-step elution
procedure.
1.Introduction
The capacity to produce antimicrobial peptides (AMPs) is
widespread among Gram-positive bacteria. These AMPs are
directed against competitive microorganisms in order to
generate a selective advantage for the producer organism [1].
AMPs can be divided in three major classes. Class I consists
of the so-called lantibiotics, which are posttranslationally
modiﬁed peptides containing (methyl-)lanthionines, and
have a typical size of <5kDa. Class II comprises heat-stable,
nonmodiﬁed peptides of 37–58 amino acids (typical size of
<10kDa) with the leader peptide, as for Class I AMPs, being
removed during maturation. Class III contains AMPs that
are heat labile and that are generally larger in size (roughly
30kDa). Especially heat-stable peptides secreted by lactic
acid bacteria have been studied extensively because of their
potential use as natural preservatives in the food industry.
One of the best characterized AMPs is nisin, which is
secreted by Lactococcus lactis and is a member of the Class
I AMPs (for comprehensive reviews, see [2, 3]). Although
nisin has been used as a food preservative for more than
ﬁfty years, no signiﬁcant bacterial resistance against nisin
has been reported [4]. Nisin, encoded by the nisA gene, is
a (methyl-)lanthionine ring containing peptide that is ribo-
somally synthesized as a prepeptide consisting of 57 amino
acids. The NisA prepeptide is modiﬁed posttranslationally
by the dehydratase NisB, which selectively dehydrates Serine
and Threonine residues, and by the cyclase NisC, which
catalyzes lanthionine ring formation. NisT ﬁnally transports
the modiﬁed prenisin across the cell membrane, and mature,
biologically active nisin is produced upon cleavage of the
leader peptide by the extracellular, membrane-anchored
protease NisP. Mature nisin harbors three dehydrated amino
acids (one dehydrobutyrine and two dehydroalanines), one
lanthionine ring, and four methyl-lanthionine rings. In
particular, these intramolecular rings are important for the
biological activity of nisin [5]. It is worth mentioning that
nisin induces its own synthesis via interaction with the two-
component regulatory system NisRK.
Nisin is active against Gram-positive bacteria and exerts
two killing mechanisms. Firstly, nisin inhibits cell-wall syn-
thesisbybindingtolipidII,anessentialmembrane-anchored
cell-wall precursor, and secondly, nisin permeabilizes the
target membrane. The binding of nisin to lipid II induces
membrane integration of nisin resulting in the formation
of a pore, likely composed of eight nisin and four lipid II2 International Journal of Peptides
molecules [6]. This highly speciﬁc interaction with lipid II is
reﬂected by the low nano- to micromolar concentrations of
nisin, suﬃcient to permeabilize the membrane of the target
cells [7].
The bactericidal activity of AMPs is generally measured
by quantifying growth inhibition of an AMP-sensitive target
organism, grown either on agar plates or in liquid culture.
On agar plates, zones of growth inhibition of the indicator
organism can be easily visualized, and these so-called halo
assays allow determination of the minimum inhibitory
concentration (MIC) of the tested AMP [8]. Alternatively,
bacterial growth can be monitored in liquid culture in
dependence of the AMP concentration, by measuring the
opticaldensity.Thismethodallowsthesimpledetermination
of both the MIC and the IC50, that is, the concentration of
AMP that inhibits cell growth by 50% [9].
Nisin from L. lactis, like almost all naturally produced
AMPs, can be puriﬁed directly from the culture medium
[10, 11]. It is a cationic peptide, and therefore, commonly
puriﬁed using cation exchange chromatography (cIEX) at
acidic pH, using high salt concentration for elution, typically
a single-step elution with 1MNaCl [12–16]. By using nisin
puriﬁed via such a method, the IC50 and MIC values were
determined for a variety of bacteria, such as various L.
lactisstrains,Enterococcusfaecium,Bacillusanthracis,Bacillus
subtilis, Staphylococcus aureus, and Streptococcus mutans [9,
17]. Whereas E. faecium and S. mutans were equally sensitive
to nisin exhibiting an IC50 of 5μM and MIC of 12.5μM, L.
lactis HP was much more sensitive to nisin, with an IC50
of 14nM and MIC of 32nM [9]. Nisin shows promising
activity towards clinical isolates of the Methicillin-resistant
Staphylococcus aureus (MRSA) bacterium, Streptococcus pyo-
genenes, and several of the most severe human pathogens,
including the multiresistant Streptococcus pneumoniae and
vancomycin-resistant E. faecium or E. faecalis, against which
new eﬀective antibiotics are most urgently needed [18–
20]. In all these, studies puriﬁed nisin was used and the
bactericidal activity of nisin was measured by determining
the MIC or IC50.
Here, we describe a rapid and easy nisin puriﬁcation
protocol, optimized to yield active, monomeric nisin. For
this purpose, nisin was either produced from L. lactis strain
NZ9700 or purchased in the form of a lyophilized powder
that contains 2.5% (w/w) nisin. Nisin from both sources was
puriﬁed and tested for bactericidal activity using the nisin-
sensitive L. lactis NZ9000 strain. During the puriﬁcation
low molecular weight contaminants are removed, which
results in puriﬁed nisin with high speciﬁc activity. This
allows a more accurate and reproducible determination of
the biological activity of nisin.
2.MaterialandMethods
2.1. Production and Puriﬁcation of Nisin
2.1.1. Nisin Produced by L. Lactis. A culture of the L. lactis
strain NZ9700 was grown overnight in M17 medium con-
taining 0.5% (w/v) glucose (GM17) at 30◦C. Next, 100mL
of the overnight culture was used to inoculate 2l of
GM17, and cells were grown at 30◦C. At an OD600 of
0.8, the culture was supplemented with nisin (Sigma) to a
ﬁnal concentration of 1ng/ml cell culture to ensure nisin
production and growth was continued over night. Next,
cells were removed by centrifugation (30min., 6000xg at
4◦C). The supernatant was used and diluted with 1l of
50mM lactic acid pH 3 resulting in a 3l solution with
a pH of 5. This solution was loaded on a 5mL HiTrap
SP HP cation exchange (cIEX) column (GE Healthcare)
using a ﬂow rate of 4mL/min. Due to the large volume,
this step is optimally performed overnight. Protein elution
was monitored by measuring the absorbance at 215nm.
Unfortunately, it is not possible to detect nisin at 280nm,
because it does not contain any aromatic amino acids;
therefore, the 215nm was chosen as wavelength. The column
was subsequently washed with 50mM lactic acid pH 3
until a stable baseline was reached to remove nonspeciﬁcally
bound material. Peptides were eluted by increasing the
NaCl concentration stepwise using a ﬂow rate of 1mL/min,
resulting in elution fractions with 200mM (Step I), 400mM
(Step II), 600mM (Step III), 800mM (Step IV) and 1M
(Step V) NaCl. To remove NaCl, protein in the elution
fractionswasprecipitatedwith20%(v/v)trichloroaceticacid
(TCA)overnightat4◦C.Precipitatedproteinwaswashedtwo
times with ice-cold acetone to remove residual TCA. Finally,
the protein pellet was suspended in 50mM lactic acid pH
3. Nisin concentrations were determined by a colorimetric
assay (Pierce BCA Protein Assay Kit, Thermo scientiﬁc)
by measuring the absorbance at 584nm according to the
protocol of the manufacturer.
2.1.2. Purchased Nisin. Commercial nisin (Sigma) is avail-
able as a lyophilized powder containing ∼2.5% (w/w) nisin.
1.3g of nisin powder (corresponding to 32.5mg nisin) was
dissolved in 100mL 50mM lactic acid pH 3 and ﬁltered
through a 0.45μm membrane ﬁlter (Pall Corporation).
The nisin solution was applied to a 5mL HiTrap SP HP
cation exchange column (GE Healthcare) at a ﬂow rate
of 2mL/min, whereas elution was performed at a ﬂow
rate of 1mL/min. Nisin puriﬁcation, precipitation, and
concentration determination were carried out as described
above.
2.2. Tricine-SDS-PAGE. Tricine-SDS-PAGE was essentially
carried out as described in [21]. For analysis, 16μLs a m p l e
was supplemented with 4μL 5x SDS sample buﬀer (0.2M
Tris-HCl, pH 6.8, 10% (w/v) SDS, 40% (v/v) glycerol, 0.02%
(w/v) bromophenol blue, and 10mM DTT) and loaded
on a tricine gel consisting of a stacking gel containing 5%
acrylamide and a separation gel containing 16% acrylamide.
The gel was run at 100V for 2 hours, and proteins were
detected via silver staining. For all puriﬁcation fractions,
3.2μg of total protein was analyzed.
2.3. MALDI-TOF Mass Spectrometry. Samples obtained
from cIEX chromatography were precipitated with TCA and
washed with acetone as described above. The protein pelletsInternational Journal of Peptides 3
werethendriedfor15min.at30◦Cinavacuumconcentrator
(Eppendorf concentrator plus). Dried pellets were stored
at −20◦C until analysis. For mass spectrometric analysis,
the samples were dissolved in water with 1% (v/v) formic
acid. Measurements were performed using a MALDI-TOF
instrument (Voyager-DE STR, Applied Biosystems) with a
nitrogenlaser(λ = 337nm)operatinginreﬂectormodewith
25kV acceleration voltage. The samples were prepared by
the standard dried-droplet procedure, by applying 0.5μLo f
2,5-dihydroxybenzoic acid (DHB) matrix solution (10mg in
1mL water) plus 0.5μL of sample solution. The droplet was
dried by a gentle ﬂow of air. An external calibration with the
monomer ion of des-Pro-Bradykinin, Sub P, Bombesin, and
Melittin was used. The spectrum was obtained by averaging
200 laser shots.
2.4. IC50 Determination of Nisin. To investigate the antimi-
crobial activity of nisin, the nisin sensitive L. lactis strain
NZ9000 [22]wasgr o wni na9 6 - w ellp l at ei nG M1 7m ed i um .
The total volume in each well was 200μL, consisting of 50μL
sample and 150μL GM17 containing L. lactis NZ9000 cells
(starting OD600 = 0.1). Samples were prepared by diluting
nisin obtained from various cIEX elution fractions in 50mM
lactic acid pH 3 to yield ﬁnal protein concentrations ranging
from 0.15nM to 300nM in the wells. 50mM lactic acid pH
3 without protein served as positive growth control. Cells
weregrownat30◦C,andtheopticaldensitywasmonitoredat
620nm every 20min for a period of 8 hours (96 plate reader
BMG). To determine the IC50 values, the optical density
was normalized and plotted against the log of the nisin
concentration. Data were evaluated according to
Y =
OD min+(OD max−OD min)
1+10 ((log(IC50)−X)∗slope) . (1)
The ODmax value describes the normalized OD600 value in
the starting plateau. The ODmin value corresponds to the
normalized OD600 of the end plateau value. Y stands for
the normalized optical density value, and X represents the
logarithmic concentration of the peptide. The IC50 value
is calculated as the value of the peptide concentration
used where the growth inhibition (or OD600) is 50%. This
corresponds to the inﬂection point of the resulting curves.
2.5. Growth Inhibition Visualized by a Halo Assay. The
antimicrobial activity of the diﬀerent nisin preparations
was assessed by means of a halo assay. Puriﬁed nisin
obtained from the diﬀerent cIEX elution fractions were
supplemented (16μL) with 4μL of 5x SDS sample buﬀer
and tricine-SDS-PAGE was carried out as described above.
After electrophoresis the gel was incubated for 30min in
an aqueous solution containing 20% (v/v) isopropanol and
10% (v/v) acetic acid. Subsequently, the gel was washed two
times for 30min in ddH2O. At this stage, the gel was kept
in ddH2Oa t8 ◦C until usage. Finally, the gel was overlaid
withGM17-agar(0.5%w/vagar)containingL.lactisNZ9000
cells at an OD600 of 0.1. After solidiﬁcation, the overlaid
gel was incubated overnight at 30◦Ct oa l l o wf o rb a c t e r i a l
growth. The bactericidal activity of nisin is readily visualized
by the presence of clear zones (halos) resulting from growth
inhibition.
3. Results
3.1. Puriﬁcation of Nisin
3.1.1. Lyophilized Commercial Nisin. To determine the
antimicrobial activity of commercially available nisin, we
used a lyophilized powder, which contains ∼2.5% (w/w)
nisin. To further purify nisin, we initially performed SP
Sepharose cation exchange chromatography using 1MNaCl
to elute the bound nisin. Subsequent SDS-PAGE analysis
of the eluate revealed a major protein band corresponding
to a peptide with a molecular mass of about 3.5kDa (data
not shown) in line with the calculated mass of 3354Da
for mature nisin. However, several higher molecular weight
components were also present. It is of note that these con-
taminants are not readily visualized by Coomassie Brilliant
Blue staining, whereas these impurities are clearly detected
by silver staining. Nisin puriﬁed via this method showed
antimicrobial activity against L. lactis NZ9000 exhibiting an
IC50 of 30 ±12nM.
The presence of contaminants prompted us to optimize
the puriﬁcation of nisin. We ﬁrst tested elution with a
linear gradient (50 times the column volume) ranging from
0–1MNaCl. This approach, however, resulted in a broad
peak eluting throughout the NaCl gradient and further
analysis revealed no improvement when compared to the
single-step 1MNaCl elution (data not shown). In contrast,
a substantial improvement was achieved when a ﬁve-step
NaCl step gradient was used to elute nisin from the cIEX
column (Figure 1(a)). Bound protein eluted at every step
as evidenced by the elution proﬁle and subsequent tricine-
SDS-PAGEanalysis(Figure2(a)).TheStepIIelutionfraction
contained the bulk of nisin as evident by the major protein
band with a corresponding molecular mass of ∼3.5kDa,
whereas substantially lower amounts of nisin were detected
in elution fractions I, III, and IV. In the Step V fraction
no nisin was visible. The Step I and II elution fractions
contained exclusively nisin, while elution fractions III–V
contained predominantly higher molecular weight com-
pounds (ranging from 6kDa–70kDa). In the latter fractions
compounds with molecular weights of ∼8kDa and ∼10kDa
were most prominent. The total protein concentration of the
elution fractions was determined to be: 2.1mg/mL for Step
I (200mMNaCl), 7.5mg/mL for Step II (400mMNaCl),
1.9mg/mL for Step III (600mMNaCl), 0.5mg/mL for Step
IV (800mMNaCl) and 0.4mg/mL for Step V (1MNaCl)
(Table 1). In Step II, ∼60% of the total puriﬁed nisin eluted.
Thus, it appears that 400mMNaCl is suﬃcient to elute the
vast majority of the nisin molecules. More importantly, the
nisin eluting under these conditions is essentially devoid of
contaminants.
3.1.2. Nisin Produced by L. Lactis. An alternative to pur-
chasing nisin is to produce it in the laboratory, since L.
lactis strains that secrete nisin in large amounts are readily4 International Journal of Peptides
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Figure 1: Puriﬁcation of nisin via cation exchange chromatography. The elution proﬁles of the puriﬁcation of commercial nisin (a) and
nisin produced by L. lactis NZ9700 (b) are shown. In both cases, nisin is eluted from the column using a ﬁve-step gradient with 200mM
(Step I), 400mM (Step II), 600mM (Step III), 800mM (Step IV) and 1MNaCl (Step V). The diﬀerent elution steps and corresponding
NaCl concentrations are indicated by the dashed line and the right y-axis, respectively. Protein was detected by measuring the absorbance at
215nm.
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Figure 2: Tricine-SDS-PAGE analysis of the cIEX puriﬁcation of nisin. Puriﬁcation of commercial nisin (a) and nisin secreted by the L.
lactis NZ9700 strain (b). M, marker proteins; I, elution with 200mMNaCl; II, elution with 400mMNaCl; III, elution with 600mMNaCl;
IV, elution with 800mMNaCl; V, elution with 1MNaCl. Protein was visualized by silver staining. The three lowest marker proteins are
indicated with molecular weights (kDa).
Table 1:IC50 valuesofeachnisincontainingfractionelutedfromthecIEXcolumn.Valuesarecombineddatafromatleastthreeindependent
nisin puriﬁcations and subsequent inhibition experiments.
Purchased nisin NZ9700 secreted nisin
Elution step IC50 (nM) Yield (mg) IC50 (nM) Yield (mg)
Step I (200mM) 35.1 ±0.1 4.2 n.i. 0.06
Step II (400mM) 2.6 ±0.1 15.1 11.2 ± 0.3 5.90
Step III (600mM) 6.9 ±0.2 3.8 n.i. 3.29
Step IV (800mM) 27.0 ±0.2 1.1 n.i. 0.14
Step V (1M) n.i. 0.8 n.i. 0.45
n.i = no inhibition observed under the experimental setup.International Journal of Peptides 5
available. We used L. lactis NZ9700 grown in GM17 medium
to produce nisin (see Section 2). Culture supernatant con-
taining nisin was subjected to cIEX chromatography using
the same ﬁve-step NaCl elution gradient as described above.
Here, a high absorbance at 215nm occurred at the Step I
elution (Figure 1(b)), but this did not correspond to nisin
or other proteins as evidenced by silver-staining following
SDS-PAGE analysis (Figure 2(b), lane 2). Likely, this high
absorbance is due to ingredients from the growth medium,
which contains large amounts of peptone, tryptone, and
yeast extract. This was conﬁrmed by a run with only GM17
media (data not shown). The remainder of the elution
proﬁle is similar to that of the lyophilized nisin puriﬁcation,
with two major absorbance peaks observed for the Step
II and III fractions (Figure 1(b)). Analysis of the protein
content of the diﬀerent elution fractions revealed that nisin
is exclusively found in the 400mMNaCl elution fraction
(Figure2(b)).Thetotalproteinconcentrationofthe400mM
elution fraction was 2.9mg/mL. However, whereas nisin is
most prominent in this fraction, components with a MW ∼
6kDa, ∼10kDa, and ∼12kDa are also present. The 0.6–1M
elution fractions on the other hand contained compounds
with molecular weights ranging from 8kDa–70kDa, similar
to those observed for the puriﬁcation of lyophilized nisin
(Figures 2(a) and 2(b)). When compared to the puriﬁcation
of lyophilized nisin, nisin puriﬁed from GM17 medium
still contained contaminants. This diﬀerence in purity may
relate to diﬀerences in the loaded material. The lyophilized
nisin powder (also containing denatured milk solids) was
dissolved in 50mM lactic acid, whereas nisin produced by L.
lactis NZ9700 was applied to the cationic exchange column
as a 1:2 mixture of GM17 culture medium and 50mM lactic
acid, respectively.
We considered the possibility that the compounds with
molecularweightsof6–8kDamayrepresenttheunprocessed
form of nisin. Immature nisin, that is, nisin still containing
the leader sequence, has a molecular weight of 5.9kDa
and may arise if ineﬃcient leader cleavage by the protease
NisP occurs. We therefore performed Western-blot analysis
using a polyclonal antibody raised against the nisin leader
sequence. Puriﬁed prenisin secreted by a L. lactis strain
lacking NisP was used as a positive control for Western-
blot analysis [23]. For all elution fractions, no signals were
observed suggesting that the observed compounds are not
derived from prenisin (data not shown).
3.2. Biological Activity of Nisin. To test the biological activity
of the puriﬁed nisin, we used L. lactis NZ9000 as indicator
organism. L. lactis NZ9000 is a derivative of the plasmid-
curedL.lactisMG1363andcontainsthenisRK genesinserted
in the chromosomal pepN locus [24]. This strain is com-
monly used as the host for nisin-induced expression system
(NICE) purposes [25]. However, since this strain lacks the
nisin immunity genes nisIFEG, it is sensitive to nisin [22].
The antimicrobial activities associated with the diﬀerent
elution fractions obtained as described above were tested in a
so-calledhaloassay.Forthis,thevariousfractionscontaining
nisin were analyzed by tricine-SDS-PAGE and the tricine
gel was overlaid with GM17-agar containing nisin sensitive
bacteria (see Section 2). The biological activity of nisin is
visualized by the growth inhibition zones (halos) at the
positionwherenisinispresent.Theresultsforthelyophilized
and the laboratory produced nisin are shown in Figures
3(a) and 3(b), respectively. After overnight incubation at
30◦C halos were observed for elution Step I–IV for the
lyophilized nisin, while for the produced nisin, a halo was
only observed for elution fraction II. For both puriﬁcations,
the highest level of growth inhibition was observed for
fraction II. Importantly, the zones of inhibition are located
only at the position of the 3.5kDa nisin peptide (Figure 3).
Thus, puriﬁed nisin was biologically active and no growth
inhibitory activity is associated with the higher molecular
weight compounds.
3.3. Mass Spectrometry. To assess and conﬁrm the presence
of nisin in the individual cIEX elution fractions (Step II–
V) of the lyophilized nisin puriﬁcation, we applied MALDI-
TOF mass spectrometry. The 400mMNaCl elution fraction
contained only one peptide with a molecular mass of
3355.09Da (Figure 4), which is in agreement with the
calculated mass of 3354.07Da for nisin. Peak integration of
the total mass spectrum revealed that the 400mM elution
fraction contains >98% of nisin, indicating that this fraction
is essentially devoid of contaminants. Nisin was also found
in the 600 mM and 800 mM elution fractions, whereas nisin
was not detected in the 1 M NaCl fraction. These results are
in agreement with tricine-SDS-PAGE analysis (Figure 2(a)).
However, the 0.6–1MNaCl elution fraction contained
several peptides with higher molecular masses. Subsequent
tandem MS analysis of these peptides yielded in-sequence
tags of eight amino acids and six amino acids, which unfor-
tunately could not be assigned to speciﬁc proteins. This was
due to the fact that the obtained sequence tags were too short
and when blasted gave multiple diﬀerent protein hits (data
notshown).Nevertheless,theobtainedsequencetagsdidnot
match with the primary sequence of (pre)nisin. Therefore,
it can be excluded that the peptide contaminants with
molecular masses of ∼6–8kDa are derived from prenisin.
3.4.AntimicrobialActivityofPuriﬁedNisin. Toquantitatively
assess the growth inhibitory activity of nisin obtained from
the diﬀerent puriﬁcation fractions, a liquid culture assay was
performed using L. lactis NZ9000 as reporter organism. The
optical density of the L. lactis NZ9000 cultures after 5 hours
of growth was plotted against the total protein concentration
of the nisin puriﬁcation fractions. Results are shown for
both, the lyophilized (Figure 5(a)) and the produced nisin
(Figure 5(b)), respectively. The resulting growth curves and
the calculated IC50 values are shown in Figure 5 and Table 1,
respectively.
For lyophilized nisin, all cIEX elution fractions exhibited
growth inhibitory activity, however, with very distinct IC50
values (Figure 5(a) and Table 1). The Step II elution
fraction displayed the highest bactericidal activity with an
IC50 of 2.6 ± 0.1nM. The other elution fractions showed
substantially higher IC50 values. Whereas the Step V elution6 International Journal of Peptides
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Figure 3: Bactericidal activity of the various nisin puriﬁcation fractions. Equal amounts of protein of the diﬀerent elution fractions (Step
I–V) from the puriﬁcation of commercial nisin (a) and from nisin secreted by the L. lactis NZ9700 strain (b) were run on a tricine-SDS-PA
gel and overlaid with nisin-sensitive L. lactis NZ9000 cells (see Section 2). The position of marker proteins with known molecular weight
(kDa) are indicated on the left. The growth inhibition zones are visible as dark areas. Lanes I–V represent the ﬁve diﬀerent elution fractions
of the cation exchange chromatography. For both puriﬁcations, maximum growth inhibition is observed for the Step II elution fraction
(400mMNaCl). Notably, the growth inhibition zone is only visible at a position of ∼3.5kDa.
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Figure 4: MALDI-TOF mass spectrometry analysis of puriﬁed
nisin. Mass spectrum of the Step II elution fraction (400mMNaCl)
from the lyophilized nisin puriﬁcation (for corresponding tricine-
SDS-PAGE analysis, see Figure 2(a), lane II).
fraction had only an inhibitory eﬀect at the highest tested
concentrations, the Step I, III, and IV elution fractions
exhibited an IC50 value of 35.1 ± 0.1nM,6.9 ± 0.2nM,and
27.0 ± 0.2nM, respectively. Thus, the 400mMNaCl elution
fraction contains not only the bulk of nisin, it also contains
nisin that displayed the highest speciﬁc activity.
A similar observation can be made for nisin puriﬁed
from the medium (Figure 5(b)). However, here only the
400mM elution fraction shows bactericidal activity, which is
in agreement with tricine-SDS-PAGE analysis (Figure 2(b))
and the halo assay (Figure 3(b)). The calculated IC50 of
11.2 ± 0.3nM is, however, ∼4-fold higher than that of
the corresponding fraction obtained from the puriﬁcation
of lyophilized nisin. We attribute this diﬀerence to the
contaminants that are still present (Figure 2(b), lane II).
Nevertheless, for both puriﬁcations the highest bactericidal
activity is associated with the fraction that contains the
highest amount of nisin (Figures 2-3 and 5). Taken together
the data indicate that nisin obtained from the Step II elution
fraction has the highest speciﬁc activity.
To determine whether NaCl used for elution has an eﬀect
on nisin activity, we repeated the experiment and adjusted
the concentration of NaCl after elution in every fraction
to 500mM either by dilution with buﬀer without salt or
by adding buﬀer and salt. Precipitated protein from these
fractions was subsequently used for growth experiments
as described above. In all cases, the IC50 values of the
“salt experiment” were slightly higher than when measured
directly after elution, indicating that more nisin is needed to
inhibit cell growth by 50% (data not shown). This indicates
that residual salt does not have a major inﬂuence on the
activity of nisin. It can, therefore, be excluded that the
diﬀerences in IC50 values of the various nisin containing
elution fractions are induced by the amounts of NaCl used
to elute nisin from the column.
4. Discussion
AMPs produced by Gram-positive bacteria form a unique
group secreted peptides [1]. Their uniqueness of especially
the lantibiotic group of AMPs, resides in the posttransla-
tional modiﬁcations, such as dehydration of amino acids
and intramolecular thioether bridges. One of the best-
characterized AMP is nisin, a compound used for more
than 40 years in up to 80 countries as an eﬀective agent to
combat food-borne pathogens. Nisin has been puriﬁed and
its antimicrobial activity veriﬁed in numerous of studies [9].International Journal of Peptides 7
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Figure 5: IC50 determination of the nisin puriﬁcation fractions. Growth inhibition experiments were performed with nisin obtained from
the diﬀerent elution fractions of the puriﬁcations of commercial nisin (a) and of nisin secreted by the L. lactis NZ9700 strain (b). The log
of the used nisin concentration of each elution fraction is plotted against the normalized optical density of L. lactis NZ9000 after ﬁve hours
of growth. Shown are the inhibition curves for the NaCl elution fractions of 200mM (o), 400mM ( ), 600mM (∇), 800mM (♦), and 1M
(∗). Data was ﬁtted and evaluated according to (1).
Commonly,nisinandothercationicAMPsarepuriﬁedusing
a single 1MNaCl elution step, from a cIEX column at an
acidic pH [12–14, 16, 26].
The activity of AMPs is strictly dependent on the target
organism. For example, the IC50 value of nisin ranges from
14nM for L. lactis HP to 5μM for Vancomycin-resistant E.
faecium, with respective MICs of 32nM and 12.5μM[ 9].
In all these studies, it is noticeable that there is a large
variationinthesensitivitytonisinbetweenisogenicstrainsof
Gram-positivebacteria,whereassomebacteriaareinherently
resistant to nisin. There are several mechanisms by which
bacteria can become resistant to an antibiotic. The most
prominent example is the enzymatic destruction or mod-
iﬁcation of the antibiotic, thereby rendering it ineﬀective.
β-Lactamases, for example, degrade the β-lactam ring of
penicillins. A second important mechanism of resistance is
shielding of the target such that the antibiotic cannot get
accesstoit—forexample,bycell-surfacealterations(capsules
S-layers) or by active extrusion by eﬄux pumps. Moreover,
the resistance of the AMP producer organism towards its
secreted AMP (autoimmunity) is typically based on ATP-
binding cassette (ABC) transporters which expel the AMP
from the membrane.
In L. lactis NZ9700, cells autoimmunity is mediated by
the scavenger protein NisI and the ABC transporter NisFEG
[5]. L. lactis cells lacking the NisIFEG defense system (e.g.,
L. lactis NZ9000) are sensitive to nisin and can be used as
indicatororganismtomeasurethebiologicalactivityofnisin.
The nisI and nisFEG genes are part of the nis operon and
are expressed in concert with the genes involved in nisin
production and secretion. Recently, in nisin-non-producing
L. lactis, nisin resistance was shown to be conferred by a
speciﬁc nisin resistance gene (nsr), which encodes a 35kDa
nisin resistance protein (NSR). NSR proteolytically removes
the last six amino acids of nisin, thereby reducing its
bactericidal activity by a factor of 100 [27].
The level of intrinsic resistance and the employed
mechanismsofantibioticresistancemaydiﬀergreatlyamong
microorganisms. It is, therefore, diﬃcult, if not impossible,
to directly compare IC50 values for a given AMP when
comparing strains. Moreover, the purity of the AMP prepa-
ration is of great importance to determine accurately the
bactericidal activity of the AMP.
In this study, we optimized the puriﬁcation of the AMP
nisin and determined its IC50 values against the nisin-
sensitive L. lactis strain NZ9000. Nisin typically puriﬁed
via a 1MNaCl one-step elution yields high levels of active
nisin (see above and [28]) but contains a substantial amount
of contaminants. We show that these contaminants, which
are mainly proteinaceous in nature, are largely removed by
using a ﬁve-step NaCl elution. Notably, 400mM NaCl (Step
II) was suﬃcient to elute the bulk of the nisin molecules,
while the majority of contaminants remain bound to the
column. In this manner, a nisin preparation was obtained
that exhibited a high speciﬁc activity. When tested against
the nisin-sensitive L. lactis NZ9000, this highly active nisin
exhibited an IC50 of 2.6 ± 0.1nM, which is a 10-fold
improvement as compared to the nisin obtained via the one-
step elution. The potent bactericidal activity of nisin against
L. lactis NZ9000 lacking NisI and NisFEG suggests that these8 International Journal of Peptides
autoimmunity proteins are of great importance for L. lactis
cells that produce nisin (e.g., L. lactis NZ9700).
AMPs get more and more into the focus of biochemical,
biophysical, and medical studies due to their antimicrobial
activity against a wide variety of bacteria. Here, we report
an easy and rapid protocol for the puriﬁcation of highly
activenisin, puriﬁed either directly fromthe culturemedium
or from a commercially available lyophilized powder. Our
studies demonstrate the importance of obtaining AMP
preparations with high speciﬁc activity. A pure, homoge-
nous, and biologically active preparation will ensure reliable
determination of the eﬃcacy of AMPs towards their micro-
bial target(s). Due to the similar chemical and biophysical
properties of lantibiotics, our manner of puriﬁcation may
also apply to AMPs other than nisin.
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